Logo

Current Standards and Emerging Therapies in Thoracic Malignancies

"Current Standards and Emerging Therapies in Thoracic Malignancies" is an interactive, gamified activity focused on the latest advancements in thoracic cancer management. Through multiple-choice questions with immediate feedback and leaderboard tracking, participants gain insights into current standards and cutting-edge therapies to enhance clinical decision-making in thoracic oncology.

Course Accreditations

This activity is supported with Independent Medical Education Grants from: Exact Sciences MSD Varian Medical Systems 1 AMA PRA Category 1 Credit™ The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 1.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission. 1 Nursing Contact Hours Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 1.00 Contact Hours. 1 ABIM MOC II Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Course Summary

    Target Audience

  • Medical Oncologists
  • Radiation Oncologists
  • Pathologists
  • Oncology Fellows
  • Oncology Nurses
  • Nurse Practitioners
  • Physician Assistants
  • Pharmacists

    Learning Objectives

    Upon successful completion of this educational activity, participants will be able to:

  • Review current standards of care for managing thoracic malignancies
  • Examine emerging therapies and their clinical applications in the treatment of thoracic cancers
  • Apply recent advancements to enhance personalized treatment planning and optimize patient outcomes in thoracic oncology